Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung

Cancer

Volumn 106, Issue 7, 2006, Pages 1595-1601

  Hashimoto, Hiroshi ^a   Ozeki, Yuichi ^a   Sato, Mitsuharu ^a   Obara, Kiyohaya ^a   Matsutani, Noriyuki ^a   Nakagishi, Yoshinori ^a   Ogata, Toshiro ^a   Maehara, Tadaaki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Cell proliferation; Ki 67 labeling index; Lung adenocarcinoma; Real time reverse transcriptase polymerase chain reaction; Thymidylate synthase

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE;

EID: 33645823401     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21777     Document Type: Article

References (42)

1. Santi DV, Danenberg PV. Folates in pyrimidine nucleotide biosynthesis. New York: Wiley-Liss; 1984:345-231.
2. Heidelberger C. Fluorinated pyrimidine and their nucleotides. In: Sartorelli AC, Johns DG, editors. Handbook of experimental pharmacology. New York: Springer; 1975:193-231.
3. Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 1996;14:1048-1054.
4. Langenbach RJ, Danenberg PV, Heidelberger C. Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res Commun. 1972;48:1565-1571.
5. Johnston PG, Fisher ER, Rockette HE, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol. 1994;12:2640-2647.
6. Johnston PG, Lenz HJ, Leichman CG, et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res. 1995;55:1407-1412.
7. Lenz HJ, Danenberg KD, Leichman CG, et al. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res. 1998;4:1227-1234.
8. Lenz HJ, Hayashi K, Salonga D, et al. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res. 1998;4:1243-1250.
9. Yamachika T, Nakanishi H, Inada K, et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer. 1998;82:70-77.
10. Edler D, Kressner U, Ragnhammar P, et al. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res. 2000;6:488-492.
11. Ishikawa Y, Kubota T, Otani Y, et al. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer. Anticancer Res. 1999;19:5635-5640.
12. Tsujitani S, Konishi I, Suzuki K, et al. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients. J Exp Clin Cancer Res. 2000;19:189-195.
13. Pestalozzi BC, Peterson HF, Gelber RD, et al. Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol. 1997;15:1923-1931.
14. Romain S, Spyratos F, Descotes F, et al. Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter study. Int J Cancer. 2000;87:860-868.
15. Kuniyasu T, Nakamura T, Tabuchi Y, Kuroda Y. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness. Cancer. 1998;83:1300-1306.
16. Suda Y, Kuwashima Y, Shioya T, Uchida K, Tanaka Y. [The expression of thymidylate synthase and thymidine phosphorylase in the early-stage of gastric cancer] [in Japanese]. Gan To Kagaku Ryoho. 1999;26:321-327.
17. Romain S, Bendahl PO, Guirou O, Malmstrom P, Martin PM, Ferno M. DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients. Int J Cancer. 2001;95:56-61.
18. Kosaka A, Mori K, Shikata A. [Significance of tissue PyNPase, TS, and DPD activities in breast cancer] [in Japanese]. Gan To Kagaku Ryoho. 2002;29:1395-1401.
19. Sanguedolce R, Vultaggio G, Sanguedolce F, et al. The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer. Anticancer Res. 1998;18:1515-1520.
20. Nakagawa T, Tanaka F, Otake Y, et al. Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung. Lung Cancer. 2002;35:165-170.
21. Higashiyama M, Kodama K, Yokouchi H, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil. Lung Cancer. 2001;34:407-416.
22. Derenzini M, Montanaro L, Trere D, et al. Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines. Mol Pathol. 2002;55:310-314.
23. Nomura T, Nakagawa M, Fujita Y, Kanada T, Mimata H, Nomura Y. Clinical significance of thymidylate synthase expression in bladder cancer. Int J Urol. 2002;9:368-376.
24. Allegra CJ, Parr AL, Wold LE, et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol. 2002;20:1735-1743.
25. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
26. Johnson MR, Wang K, Smith JB, Heslin MJ, Diasio RB. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem. 2000;278:175-184.
27. Kasahara M, Takahashi Y, Nagata T, et al. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Clin Cancer Res 2000;6:2707-2711.
28. Shoji M, Dobashi Y, Morinaga S, Jiang SX, Kameya T. Tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol 1999;154:909-918.
29. Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K. Thymidylate synthase expression in epithelial ovarian cancer: relationship with thymidine phosphorylase expression and prognosis. Oncology. 2000;59:152-157.
30. Mizutani Y, Wada H, Ogawa O, et al. Prognostic significance of thymidylate synthase activity in bladder carcinoma. Cancer. 2001;92:510-518.
31. Kralovanszky J, Koves I, Orosz Z, et al. Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors. Oncology. 2002;62:167-174.
32. Farrugia DC, Ford HE, Cunningham D, et al. Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. Clin Cancer Res. 2003;9:792-801.
33. Mizutani Y, Wada H, Yoshida O, et al. Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res. 2003;9:1453-1460.
34. Shintani Y, Ohta M, Hirabayashi H, et al. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction. Int J Cancer. 2003;104:790-795.
35. Navalgund LG, Rossana C, Muench AJ, Johnson LF. Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem. 1980;255:7386-7390.
36. Mirjolet JF, Barberi-Heyob M, Merlin JL, et al. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity. Br J Cancer. 1998;78:62-68.
37. Chu E, Voeller DM, Jones KL, et al. Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Mol Cell Biol. 1994;14:207-213.
38. Chu E, Allegra CJ. The role of thymidylate synthase as an RNA binding protein. Bioessays. 1996;18:191-198.
39. Liu J, Schmitz JC, Lin X, et al. Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta. 2002;1587:174-182.
40. Peters GJ, van der Wilt CL, van Triest B, et al. Thymidylate synthase and drug resistance. Eur J Cancer. 1995;31A:1299-1305.
41. Rustum YM, Harstrick A, Cao S, et al. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol. 1997;15:389-400.
42. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004;350:1713-1721.